Cat.#: ACPP-1367
| Despition | Myocilin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1278 | EAAT1 Blocking Peptide (AC1278) | 250 µg | inquiry |
| ACPP-1773 | Human LIN28 Protein (AC1773) | 2 µg | inquiry |
| ACPP-1382 | Human EYA2 Protein (AC1382) | 2 µg | inquiry |
| ACPP-1720 | Human PNPO Protein (AC1720) | 5 µg | inquiry |
| ACPP-1448 | Human I TAC Protein, His (AC1448) | 5 µg | inquiry |
| ACPP-1515 | Human ARSA Protein (AC1515) | 5 µg | inquiry |
| ACPP-1337 | Neurochondrin Blocking Peptide (AC1337) | 250 µg | inquiry |
| ACPP-1534 | Human RLN3 Protein (AC1534) | 5 µg | inquiry |
| ACPP-1611 | Human ICA69 Protein (AC1611) | 100 µg | inquiry |
| ACPP-1717 | Mouse LIF Protein (AC1717) | 3 x 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.